|
Volumn 7, Issue 3, 1997, Pages 239-243
|
Pharmacology of therapeutic oligonucleotides
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTISENSE OLIGONUCLEOTIDE;
ANTIVIRUS AGENT;
MESSENGER RNA;
OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;
BLOOD TOXICITY;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG ABSORPTION;
DRUG BILE LEVEL;
DRUG CLEARANCE;
DRUG DISTRIBUTION;
DRUG EXCRETION;
DRUG HALF LIFE;
DRUG STABILITY;
DRUG TARGETING;
GENE REPRESSION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INTRADERMAL DRUG ADMINISTRATION;
INTRAPERITONEAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LIVER TOXICITY;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SPLENOMEGALY;
SUBCUTANEOUS DRUG ADMINISTRATION;
THROMBOCYTOPENIA;
HUMAN IMMUNODEFICIENCY VIRUS;
|
EID: 0030796757
PISSN: 10872906
EISSN: None
Source Type: Journal
DOI: 10.1089/oli.1.1997.7.239 Document Type: Conference Paper |
Times cited : (13)
|
References (6)
|